Invesco Biotechnology & Genome ETF (PBE)

Market Cap: $268M

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

8% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 25

1% more capital invested

Capital invested by funds: $91.6M [Q1] → $92.3M (+$710K) [Q2]

1% less funds holding

Funds holding: 100 [Q1] → 99 (-1) [Q2]

1.39% less ownership

Funds ownership: 37.25% [Q1] → 35.86% (-1.39%) [Q2]

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8